Bruker Corporation (BRKR) just locked in a nice chunk of future revenue. The company's Bruker Energy & Supercon Technologies (BEST) division announced Friday that it signed two multi-year supply agreements with global radiology companies worth roughly $500 million combined. The deals are for advanced superconductors that go into magnetic resonance imaging (MRI) magnets, and one of the contracts stretches up to seven years.

These aren't entirely new relationships. Bruker says the agreements expand existing superconductor supply frameworks, which tells you that their customers are happy enough to keep the partnership going and scale it up. The demand signal here is clear: advanced MRI magnet technology continues to be a growth area.

Why These Superconductors Matter

Under the expanded agreements, BEST will supply superconductors engineered to meet the demanding performance and quality standards required for MRI magnets. The deliveries will primarily support MRI magnet production facilities in the United States and United Kingdom, drawing on Bruker's manufacturing operations across Europe and the U.S.

Here's where it gets interesting: these advanced superconductors are essential for helium-free MRI magnet designs. Traditional MRI systems rely on liquid helium for cooling, which is expensive and increasingly scarce. Helium-free architectures need superconductors with exceptionally high field stability and homogeneity to work properly. Bruker's technology enables these next-generation designs, which reduce operating costs and make MRI installations more sustainable over the long term.

Beyond Medical Imaging

While MRI is the headline application, BEST's low-temperature and high-temperature superconducting technologies show up in some pretty diverse places. The same core technology gets used in proton therapy for cancer treatment, nuclear magnetic resonance and electron paramagnetic resonance spectroscopy for research, preclinical MRI systems, magnetic confinement fusion experiments, superconducting wind turbines, and high-energy physics research.

"Our OEM customers depend on performance-leading MRI systems that deliver state-of-the-art image quality with minimal downtime and at competitive cost of ownership," said Burkhard Prause, President and CEO of BEST.

"The expanded agreements demonstrate the confidence of major OEM customers in our capabilities in superconductor innovation, quality, and resilient supply chains… The expanded agreements continue important partnerships and ensure stability and growth in our superconductor business in the years to come."

Bruker shares climbed 2.57% to $53.83 on Friday following the announcement.